Rainer Boehm will join the Humanigen Inc. board Feb. 12.
Boehm was previously chief commercial and medical affairs officer for Novartis Pharma AG, a Novartis AG unit.
Brisbane, Calif.-based Humanigen is a biotechnology company developing treatments for cancer.
